NCT00151008View on ClinicalTrials.gov

Bexarotene With Narrow-Band UVB for Psoriasis

PHASE2CompletedINTERVENTIONAL

Enrollment

35

Participants

Timeline

Start Date

November 30, 2003

Study Completion Date

August 31, 2005

Conditions

Psoriasis

Interventions

DRUG

Bexarotene/NBUVB vs placebo NBUVB

Sponsors

Collaborators (1)

Ligand Pharmaceuticals

All Listed Sponsors

collaborator

Ligand Pharmaceuticals

INDUSTRY

lead

University of Medicine and Dentistry of New Jersey

OTHER

NCT00151008 - Bexarotene With Narrow-Band UVB for Psoriasis | Biotech Hunter | Biotech Hunter